Prognostic Significance of Baseline Clinical and [68Ga]Ga-PSMA PET Derived Parameters on Biochemical Response, Overall Survival, and PSA Progression-Free Survival in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Undergoing [177Lu]L
We have identified several baseline clinical and PSMA PET derived parameters that can serve as prognostic factors for predicting PSA response, OS, and PSA PFS after RLT. Based on the findings, we believe that these clinical baseline characteristics can assist nuclear medicine specialists in identifying RLT responders who have long-term survival and PFS.
Authors
- Hojjat Ahmadzadehfar (ORCID: https://orcid.org/0000-0002-0393-5309)
- Narges Jokar (ORCID: https://orcid.org/0000-0001-7565-0882)
- Ahmad Keshavarz (ORCID: https://orcid.org/0000-0002-5103-8311)
- Reyhaneh Manafi‐Farid (ORCID: https://orcid.org/0000-0003-2833-8276)
- Ghasemali Divband (ORCID: https://orcid.org/0000-0001-6011-8236)
- Esmail Jafari (ORCID: https://orcid.org/0000-0001-9249-9248)
- Farshad Zohrabi (ORCID: https://orcid.org/0000-0002-8330-6202)
- Majid Assadi (ORCID: https://orcid.org/0000-0003-3862-9472)
- Habibollah Dadgar (ORCID: https://orcid.org/0000-0001-6073-7547)
- Fatemeh Salek
Institutions
- Milad Hospital (IR)
- Klinikum Westfalen (Germany) (DE)
- Imam Reza International University (IR)
- Shariati Hospital (IR)
- Bushehr University of Medical Sciences (IR)
- Tehran University of Medical Sciences (IR)
- Persian Gulf University (IR)
Publication Details
- Journal
- Nuklearmedizin - NuclearMedicine
- Published
- 2024-09-03
- DOI
- https://doi.org/10.1055/a-2365-8113
- Citations
- 6
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 2.51